The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a ventral hernia.
It was reported that after implant, the patient experienced mesh exposed at open wound, chronic open wound, infected mesh, scar tissue, sinus tract, adhesions, staphylococcus aureus, laceration, inflammation, biofilm formed on mesh, and abdominal wall pain.
Post-operative patient treatment included lysis of adhesions, ct scan, debridement of wound/laceration, scar tissue removed, sinus tract removed, removal of mesh, inflamed tissue including umbilicus excised, tissue debridement, hernia repair with new mesh, diagnostic laparoscopy, removal of tacks, and two clips removed from subcutaneous tissue.
|